Brief: Insmed Q4 Revenue USD 104.4 Million Vs. IBES Estimate USD 102.8 Million
20/02/2025 12:00
Feb 20 (Reuters) - Insmed Q4 net income USD -235.5 million vs. IBES estimate USD -202.7 million. * Q4 EPS USD -1.32 * outlook FY revenue USD 405-425 million
Recent news on Insmed
See all newsAstera Labs, CoreWeave and others rise after Nasdaq-100 inclusion
U.S. RESEARCH ROUNDUP-Arthur J. Gallagher & Co, Datadog, Oracle
U.S. RESEARCH ROUNDUP- Adobe, Allstate, Teleflex
Brief: Insmed Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
U.S. RESEARCH ROUNDUP- CAVA Group, Eagle Materials, Vertiv Holdings